MiniMed director files initial Form 3 report

MiniMed Group, Inc. director D. Keith Grossman filed an initial Form 3 insider ownership report for MMED.

Rhea-AI Filing Summary

MiniMed Group, Inc. director D. Keith Grossman filed an initial Form 3 insider ownership report for MMED. This filing establishes his status as a director and provides a baseline disclosure of his beneficial ownership. The report shows no insider transactions or derivative positions in this submission.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MiniMed Group (MMED) Form 3 filing by D. Keith Grossman show?

The Form 3 filing shows that D. Keith Grossman is a director of MiniMed Group, Inc. It serves as his initial insider ownership report for MMED and, in this submission, reports no insider transactions or derivative security positions.

Did MiniMed Group (MMED) director D. Keith Grossman buy or sell shares in this Form 3?

No, this Form 3 does not report any share purchases or sales by D. Keith Grossman. The transaction summary shows zero buy, sell, acquire, or dispose entries, indicating this filing is purely an initial ownership disclosure without trading activity.

Does the MiniMed Group (MMED) Form 3 include any stock option or derivative positions?

No, the filing’s derivative summary is empty and the transactionSummary shows zero derivative transactions or exercises. This indicates that, in this particular Form 3 submission, no options, warrants, or other derivative securities positions are reported for D. Keith Grossman.

What insider role does D. Keith Grossman have at MiniMed Group (MMED)?

The filing identifies D. Keith Grossman as a director of MiniMed Group, Inc. He is not reported as an officer or ten-percent owner in this Form 3, making this a straightforward director-level initial beneficial ownership disclosure for MMED.

Why is this MiniMed Group (MMED) Form 3 filing important for investors?

Form 3 filings give transparency into who qualifies as an insider at a company. This filing confirms D. Keith Grossman’s director status at MiniMed Group, Inc., creating a baseline from which any future Form 4 or Form 5 trading activity can be compared.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:14 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

GROSSMAN D KEITH

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.